Phase II trial of combination interferon-alpha and thalidomide as first-line therapy in metastatic renal cell carcinoma.

Clark PE, Hall MC, Miller A, Ridenhour KP, Stindt D, Lovato JF, Patton SE, Brinkley W, Das S, Torti FM
Urology. 2004 63 (6): 1061-5

PMID: 15183950 · DOI:10.1016/j.urology.2004.01.035

MeSH Terms (18)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Carcinoma, Renal Cell Disease Progression Drug Administration Schedule Female Humans Injections, Subcutaneous Interferon-alpha Kidney Neoplasms Male Middle Aged Prospective Studies Remission Induction Survival Rate Thalidomide

Connections (1)

This publication is referenced by other Labnodes entities:

Links